2-chloroethyl-3-sarcosinamide-1-nitrosourea

[email protected]
2-chloroethyl-3-sarcosinamide-1-nitrosourea
Trade Name
Orphan Indication Treatment for malignant gliomas
USA Market Approval USA
USA Designation Date 2001-08-03 00:00:00
Sponsor Lawrence Panasci, MD;Professor of Medicine, McGill University, 3755 Cote Ste Catherine;